the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
.
as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
.
orchid pharma faces liquidation as lenders reject resolution plan
. tusk made his remarks about the u.s. president's reliability before he chaired a meeting in bulgaria of the 28 leaders whose countries make up the world's biggest trading bloc.
.